ASXC Insider Trading
Insider Ownership Percentage: 2.87%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Asensus Surgical Share Price & Price History
Current Price: $0.35
Price Change: +0.30 (1.20%)
As of 08/22/2024 01:00 AM ET
Asensus Surgical Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 12/14/2023 | William N Starling Jr | Director | Buy | 18,134 | $0.28 | $5,077.52 | 39,134 |  |
| 3/3/2023 | Andrea Biffi | Director | Buy | 293,077 | $0.71 | $208,084.67 | 492,815 | |
Asensus Surgical Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 5/20/2024 | Virtu Financial LLC | 249,019 | $57K | 0.0% | +834.4% | 0.091% |  |
| 11/6/2023 | Avantax Planning Partners Inc. | 112,936 | $30K | 0.0% | +773.0% | 0.043% | |
| 10/5/2023 | Mirador Capital Partners LP | 110,000 | $30K | 0.0% | +83.2% | 0.042% | |
| 8/14/2023 | Masters Capital Management LLC | 2,000,000 | $1.01M | 0.0% | +8.5% | 0.758% | |
| 7/20/2023 | Lazari Capital Management Inc. | 70,000 | $35K | 0.0% | N/A | 0.029% | |
| 5/12/2023 | AlphaCentric Advisors LLC | 500,000 | $0.33M | 0.2% | N/A | 0.209% | |
| 5/1/2023 | Virtu Financial LLC | 38,060 | $25K | 0.0% | -65.1% | 0.016% | |
| 2/13/2023 | GSA Capital Partners LLP | 968,036 | $0.34M | 0.0% | -3.3% | 0.409% | |
| 11/14/2022 | Ergoteles LLC | 967,987 | $0.43M | 0.0% | -7.3% | 0.409% | |
| 7/29/2022 | Walker Asset Management LLC | 310,000 | $0.14M | 0.0% | N/A | 0.131% | |
| 7/25/2022 | Walker Asset Management LLC | 310,000 | $0.14M | 0.0% | N/A | 0.131% | |
| 5/11/2022 | GSA Capital Partners LLP | 220,679 | $0.14M | 0.0% | N/A | 0.093% | |
| 5/4/2022 | Advisor Group Holdings Inc. | 279,923 | $2.09M | 0.0% | +12.3% | 0.118% | |
| 4/29/2022 | Daiwa Securities Group Inc. | 95,198 | $60K | 0.0% | +45.7% | 0.040% | |
| 2/15/2022 | D L Carlson Investment Group Inc. | 50,000 | $55K | 0.0% | N/A | 0.021% | |
| 2/14/2022 | Itau Unibanco Holding S.A. | 35,547 | $38K | 0.0% | +70.8% | 0.015% | |
| 2/10/2022 | Rafferty Asset Management LLC | 1,706,657 | $1.89M | 0.0% | +40.4% | 0.728% | |
| 2/9/2022 | Principal Financial Group Inc. | 53,632 | $59K | 0.0% | -27.9% | 0.023% | |
| 2/8/2022 | First Trust Advisors LP | 4,365,319 | $4.85M | 0.0% | +72.9% | 1.862% | |
| 2/8/2022 | ProShare Advisors LLC | 51,118 | $57K | 0.0% | +70.5% | 0.022% | |
| 2/8/2022 | Northern Trust Corp | 2,071,662 | $2.30M | 0.0% | -4.3% | 0.884% | |
| 2/7/2022 | SG Americas Securities LLC | 50,650 | $56K | 0.0% | -60.7% | 0.022% | |
| 2/7/2022 | Mitsubishi UFJ Kokusai Asset Management Co. Ltd. | 469,114 | $0.56M | 0.0% | +56.1% | 0.200% | |
| 2/3/2022 | Cambridge Investment Research Advisors Inc. | 25,971 | $29K | 0.0% | -34.4% | 0.011% | |
| 2/3/2022 | Daiwa Securities Group Inc. | 65,318 | $73K | 0.0% | +176.8% | 0.028% | |
| 2/2/2022 | Mirador Capital Partners LP | 70,039 | $78K | 0.0% | +81.7% | 0.030% | |
| 2/2/2022 | Tradewinds Capital Management LLC | 35,077 | $39K | 0.0% | -33.9% | 0.015% | |
| 12/8/2021 | Moors & Cabot Inc. | 20,238 | $0.24M | 0.0% | N/A | 0.009% | |
| 11/16/2021 | Metropolitan Life Insurance Co NY | 44,320 | $82K | 0.0% | -35.1% | 0.019% | |
| 11/12/2021 | The Manufacturers Life Insurance Company | 126,535 | $0.23M | 0.0% | -5.0% | 0.054% | |
| 11/12/2021 | Geode Capital Management LLC | 3,898,267 | $7.21M | 0.0% | +3.0% | 1.663% | |
| 11/10/2021 | Goldman Sachs Group Inc. | 212,773 | $0.39M | 0.0% | -20.2% | 0.091% | |
Data available starting January 2016
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.
Read More on Asensus Surgical
Volume
N/A
Average Volume
2,034,864 shs
Market Capitalization
$94.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.37
